BIOVECTRA – Hiring Practices – The Employment Journey on PEI

January 29, 2016

BIOVECTRA – Hiring Practices – The Employment Journey on PEI

BIOVECTRA is a custom manufacturer of pharmaceutical ingredients for pharma companies.  The company started when Dr. Regis Duffy, Dean of Science at UPEI, wanted to create summer employment for his students. Now, 45 years later, BIOVECTRA is a wholly-owned subsidiary of a publicly-traded multinational pharmaceutical company with employees working primarily on PEI, as well as Nova Scotia and elsewhere.  “We have 260 talented people with diverse backgrounds in organic chemistry, polymer chemistry, biochemistry, molecular biology, and many fields of engineering, as well as specialists in manufacturing and quality assurance,” says Heather Delage, who has worked for BIOVECTRA for 25 years.

View Article

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors